This co-funding opportunity from the Terry Fox Research Institute (TFRI) and the Marathon of Hope Cancer Centres Network (MOHCCN) aims to support the development of proof-of-principle or proof-of-feasibility data for additional profiling approaches to be used in future developments for the MOHCCN. These projects will support existing or new precision cancer research using the MOHCCN model with significant potential for impact on outcomes for patients.
Project topics may include but are not limited to:
- Proteomics and protein-based technologies
- Metabolomics
- Liquid biopsies and longitudinal samples for assessment of metastasis or heterogeneity
- Flow Cytometry, CyTOF, Imaging mass spectrometry.
Applications should detail the technology, evidence of its use in the applicant’s labs, plan for standardization, reproducibility (at more than one site), and data processing/export.
Applicants must have appropriate access to samples (include letters to demonstrate consent for sample analysis and access for sharing, as appropriate) and must detail the number of samples to be included in the project (minimum 20).
Key Dates
- Webinar: 3 April 2024 | 11am – 12pm
- A recording will be made available for those who cannot attend
- Submission Deadline: 16 May 2024 | 5pm
- Funding Announcement: July 2024
- Funding Starts: 1 August 2024
Full details can be found here, including the link to attend the webinar.